Abstract
Recurrent microdeletions and microduplications of a 600-kb genomic region of chromosome 16p11.2 have been implicated in childhood-onset developmental disorders. We report the association of 16p11.2 microduplications with schizophrenia in two large cohorts. The microduplication was detected in 12/1,906 (0.63%) cases and 1/3,971 (0.03%) controls (P = 1.2 × 10 5, OR = 25.8) from the initial cohort, and in 9/2,645 (0.34%) cases and 1/2,420 (0.04%) controls (P = 0.022, OR = 8.3) of the replication cohort. The 16p11.2 microduplication was associated with a 14.5-fold increased risk of schizophrenia (95% CI (3.3, 62)) in the combined sample. A meta-analysis of datasets for multiple psychiatric disorders showed a significant association of the microduplication with schizophrenia (P = 4.8 × 10 7), bipolar disorder (P = 0.017) and autism (P = 1.9 × 10 7). In contrast, the reciprocal microdeletion was associated only with autism and developmental disorders (P = 2.3 × 10 13). Head circumference was larger in patients with the microdeletion than in patients with the microduplication (P = 0.0007).
Original language | English (US) |
---|---|
Pages (from-to) | 1223-1227 |
Number of pages | 5 |
Journal | Nature genetics |
Volume | 41 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2009 |
ASJC Scopus subject areas
- Genetics
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Microduplications of 16p11.2 are associated with schizophrenia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Nature genetics, Vol. 41, No. 11, 11.2009, p. 1223-1227.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Microduplications of 16p11.2 are associated with schizophrenia
AU - McCarthy, Shane E.
AU - Makarov, Vladimir
AU - Kirov, George
AU - Addington, Anjene M.
AU - McClellan, Jon
AU - Yoon, Seungtai
AU - Perkins, Diana O.
AU - Dickel, Diane E.
AU - Kusenda, Mary
AU - Krastoshevsky, Olga
AU - Krause, Verena
AU - Kumar, Ravinesh A.
AU - Grozeva, Detelina
AU - Malhotra, Dheeraj
AU - Walsh, Tom
AU - Zackai, Elaine H.
AU - Kaplan, Paige
AU - Ganesh, Jaya
AU - Krantz, Ian D.
AU - Spinner, Nancy B.
AU - Roccanova, Patricia
AU - Bhandari, Abhishek
AU - Pavon, Kevin
AU - Lakshmi, B.
AU - Leotta, Anthony
AU - Kendall, Jude
AU - Lee, Yoon Ha
AU - Vacic, Vladimir
AU - Gary, Sydney
AU - Iakoucheva, Lilia M.
AU - Crow, Timothy J.
AU - Christian, Susan L.
AU - Lieberman, Jeffrey A.
AU - Stroup, T. Scott
AU - Lehtimäki, Terho
AU - Puura, Kaija
AU - Haldeman-Englert, Chad
AU - Pearl, Justin
AU - Goodell, Meredith
AU - Willour, Virginia L.
AU - Derosse, Pamela
AU - Steele, Jo
AU - Kassem, Layla
AU - Wolff, Jessica
AU - Chitkara, Nisha
AU - McMahon, Francis J.
AU - Malhotra, Anil K.
AU - Potash, James B.
AU - Schulze, Thomas G.
AU - Nöthen, Markus M.
AU - Cichon, Sven
AU - Rietschel, Marcella
AU - Leibenluft, Ellen
AU - Kustanovich, Vlad
AU - Lajonchere, Clara M.
AU - Sutcliffe, James S.
AU - Skuse, David
AU - Gill, Michael
AU - Gallagher, Louise
AU - Mendell, Nancy R.
AU - Craddock, Nick
AU - Owen, Michael J.
AU - O'Donovan, Michael C.
AU - Shaikh, Tamim H.
AU - Susser, Ezra
AU - Delisi, Lynn E.
AU - Sullivan, Patrick F.
AU - Deutsch, Curtis K.
AU - Rapoport, Judith
AU - Levy, Deborah L.
AU - King, Mary Claire
AU - Sebat, Jonathan
N1 - Funding Information: Schizophrenia: Funding support for the genome-wide association of schizophrenia study was provided by the National Institute of Mental Health (NIMH) (R01 MH67257, R01 MH59588, R01 MH59571, R01 MH59565, R01 MH59587, R01 MH60870, R01 MH59566, R01 MH59586, R01 MH61675, R01 MH60879, R01 MH81800, U01 MH46276, U01 MH46289 U01 MH46318, U01 MH79469 and U01 MH79470), and the genotyping of samples was provided through the genetic association information network (GAIN). The datasets used for the analyses described in this manuscript were obtained from the database of genotype and phenotype (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000021.v2.p1. Samples and associated phenotype data for the genome-wide association of schizophrenia study were provided by the Molecular Genetics of Schizophrenia Collaboration (PI: P.V. Gejman, Evanston Northwestern Healthcare (ENH) and Northwestern University, Evanston, Illinois, USA). Bipolar Disorder: Funding support for the whole-genome association study of bipolar disorder was provided by the NIMH and the genotyping of samples was provided through GAIN. The datasets used for the analyses described in this manuscript were obtained from dbGaP found at http://www.ncbi.nlm. nih.gov/gap through dbGaP accession number phs000017.v2.p1. Samples and associated phenotype data for the collaborative genomic study of bipolar disorder were provided by the NIMH genetics initiative for bipolar disorder. Data and biomaterials were collected in four projects that participated in the NIMH bipolar disorder genetics initiative. From 1991–1998, the principal investigators and co-investigators were: Indiana University, Indianapolis, Indiana, USA, U01 MH46282, J. Nurnberger, M. Miller and E. Bowman; Washington University, St. Louis, Missouri, USA, U01 MH46280, T. Reich, A. Goate and J. Rice; Johns Hopkins University, Baltimore, Maryland, USA, U01 MH46274, J.R. DePaulo Jr., S. Simpson and C. Stine; NIMH Intramural Research Program, Clinical Neurogenetics Branch, Bethesda, Maryland, USA, E. Gershon, D. Kazuba and E. Maxwell. Data and biomaterials were collected as part of ten projects that participated in the NIMH bipolar disorder genetics initiative. From 1999–2003, the principal investigators and co-investigators were: Indiana University, Indianapolis, Indiana, USA, R01 MH59545, J. Nurnberger, M.J. Miller, E.S. Bowman, N.L. Rau, P.R. Moe, N. Samavedy, R. El-Mallakh (at University of Louisville, Louisville, Kentucky, USA), H. Manji (at Wayne State University, Detroit, Michigan, USA), D.A. Glitz (at Wayne State University, Detroit, Michigan, USA), E.T. Meyer, C. Smiley, T. Foroud, L. Flury, D.M. Dick and H. Edenberg; Washington University, St. Louis, Missouri, USA, R01 MH059534, J. Rice, T. Reich, A. Goate and L. Bierut; Johns Hopkins University, Baltimore, Maryland, USA, R01 MH59533, M. McInnis, J.R. DePaulo Jr., D.F. MacKinnon, F.M. Mondimore, J.B. Potash, P.P. Zandi, D. Avramopoulos and J. Payne; University of Pennsylvania, Philadelphia, Pennsylvania, USA, R01 MH59553, W. Berrettini; University of California at Irvine, Irvine, California, USA, R01 MH60068, W. Byerley and M. Vawter; University of Iowa, Iowa City, Iowa, USA, R01 MH059548, W. Coryell and R. Crowe; University of Chicago, Chicago, Illinois, USA, R01 MH59535, E. Gershon, J. Badner, F. McMahon, C. Liu, A. Sanders, M. Caserta, S. Dinwiddie, T. Nguyen and D. Harakal; University of California, San Diego, La Jolla, California, USA, R01 MH59567, J. Kelsoe and R. McKinney; Rush University, Chicago, Illinois, USA, R01 MH059556, W. Scheftner, H.M. Kravitz, D. Marta, A.Vaughn-Brown and L. Bederow; NIMH Intramural Research Program, Bethesda, Maryland, USA, 1Z01MH002810-01, F.J. McMahon, L. Kassem, S. Detera-Wadleigh, L. Austin and D.L. Murphy. Funding for this study was provided by grants from T. and V. Stanley, the Simons Foundation J.M and C.D. Stone, grants from NARSAD to F.J.M., T.G.S., D.L.L., M.-C.K. and T.W., and grants from the Essel Foundation and the Sidney R. Baer, Jr. Foundation to D.L.L. and from the Margaret Price Investigatorship to J.B.P. and V.L.W. This work was supported by grants from the National Institutes of Health (NIH) Intramural Research Program, National Institutes of Health, including National Institute of Mental Health(NIMH) grant MH076431 to J.S., which reflects co-funding from Autism Speaks, and the Southwestern Autism Research and Resource Center, as well as NIH grants to J.S. (HF004222), M.-C.K., T.W. and J.M.C. (MH083989), D.L.L. and N.R.M. (MH071523; MH31340), J.M.C. (RR000037), P.F.S. (MH074027 and MH077139), J.S.S. (MH061009), L.E.D. (MH44245), T.H.S. (GM081519) and C.K.D. (MH081810; DE016442; HD04147). We gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium and the participating AGRE families. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to C.M. Lajonchere (PI). Funding for G.K., N. Craddock., M.J.O. and M.C.O. was provided by the Medical Research Council, UK, and the Wellcome Trust. The Clinical Antipsychotic Trials of Intervention Effectiveness project was funded by NIMH contract N01 MH90001. Funding was provided by the German Ministry of Education and Research BMBF (National Genome Research Network, NGFNplus, MooDS-Net grant no: 01GS08144 to SC and MN; grant no: 01GS08147 to MR). Genotyping of the Molecular Genetics of Schizophrenia study (PI Pablo Gejman) was funded by GAIN of the Foundation for the US NIH. This study makes use of data generated by the Wellcome Trust Case Control Consortium (full list of contributors is presented in the Supplementary Note). Funding for that project was provided by the Wellcome Trust under award 076113. Microarray data and clinical information were provided by GAIN. Thanks to the New York Cancer Project, P. Gregersen and A. Lee for providing population control samples. Also, we wish to thank P. Gejman and D. Levinson for helpful discussions. Special thanks to J. Watson for helpful discussions and support.
PY - 2009/11
Y1 - 2009/11
N2 - Recurrent microdeletions and microduplications of a 600-kb genomic region of chromosome 16p11.2 have been implicated in childhood-onset developmental disorders. We report the association of 16p11.2 microduplications with schizophrenia in two large cohorts. The microduplication was detected in 12/1,906 (0.63%) cases and 1/3,971 (0.03%) controls (P = 1.2 × 10 5, OR = 25.8) from the initial cohort, and in 9/2,645 (0.34%) cases and 1/2,420 (0.04%) controls (P = 0.022, OR = 8.3) of the replication cohort. The 16p11.2 microduplication was associated with a 14.5-fold increased risk of schizophrenia (95% CI (3.3, 62)) in the combined sample. A meta-analysis of datasets for multiple psychiatric disorders showed a significant association of the microduplication with schizophrenia (P = 4.8 × 10 7), bipolar disorder (P = 0.017) and autism (P = 1.9 × 10 7). In contrast, the reciprocal microdeletion was associated only with autism and developmental disorders (P = 2.3 × 10 13). Head circumference was larger in patients with the microdeletion than in patients with the microduplication (P = 0.0007).
AB - Recurrent microdeletions and microduplications of a 600-kb genomic region of chromosome 16p11.2 have been implicated in childhood-onset developmental disorders. We report the association of 16p11.2 microduplications with schizophrenia in two large cohorts. The microduplication was detected in 12/1,906 (0.63%) cases and 1/3,971 (0.03%) controls (P = 1.2 × 10 5, OR = 25.8) from the initial cohort, and in 9/2,645 (0.34%) cases and 1/2,420 (0.04%) controls (P = 0.022, OR = 8.3) of the replication cohort. The 16p11.2 microduplication was associated with a 14.5-fold increased risk of schizophrenia (95% CI (3.3, 62)) in the combined sample. A meta-analysis of datasets for multiple psychiatric disorders showed a significant association of the microduplication with schizophrenia (P = 4.8 × 10 7), bipolar disorder (P = 0.017) and autism (P = 1.9 × 10 7). In contrast, the reciprocal microdeletion was associated only with autism and developmental disorders (P = 2.3 × 10 13). Head circumference was larger in patients with the microdeletion than in patients with the microduplication (P = 0.0007).
UR - http://www.scopus.com/inward/record.url?scp=70350626873&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350626873&partnerID=8YFLogxK
U2 - 10.1038/ng.474
DO - 10.1038/ng.474
M3 - Article
C2 - 19855392
AN - SCOPUS:70350626873
SN - 1061-4036
VL - 41
SP - 1223
EP - 1227
JO - Nature genetics
JF - Nature genetics
IS - 11
ER -